Summary
Highlights
The video introduces anti-hyperlipidemic drugs, which are used to counter hyperlipidemia, a condition characterized by abnormally high levels of lipids in the blood. The speaker emphasizes that this is the final lecture for Unit 1 of Pharmacology for B.Pharma 5th semester, with notes available on the website or Telegram group.
The speaker explains that lipids are essential components of the body, transported through blood vessels. However, an increase in lipid concentration can lead to their accumulation, forming plaques in blood vessels. This condition, called atherosclerosis, narrows the vessels, increasing blood pressure and the risk of diseases like coronary artery disease, heart attacks, and strokes, which significantly raise mortality rates.
Three primary forms of lipids in the body are cholesterol, triglycerides, and phospholipids. Cholesterol is vital for producing bile acids (aiding digestion and absorption) and steroid hormones. Triglycerides serve as a primary energy source, while phospholipids form cell membranes. Since lipids are insoluble in blood, they are transported as lipoproteins. The video introduces four main types of lipoproteins: chylomicrons, VLDL, LDL, and HDL. The structure of lipoproteins, containing phospholipids, triglycerides, free cholesterol, and proteins, is also explained.
Chylomicrons, formed in the GI tract, transport triglycerides and cholesterol (more triglycerides) to body cells for energy. VLDL (Very Low-Density Lipoprotein), produced in the liver, also delivers triglycerides and some cholesterol. LDL (Low-Density Lipoprotein) is formed from VLDL after releasing triglycerides and contains a high percentage of cholesterol. The liver takes up LDL to produce bile acids. HDL (High-Density Lipoprotein) is produced by the liver and small intestine and acts as a 'good' cholesterol by collecting excess cholesterol from blood vessels and returning it to the liver for excretion. When LDL levels are too high, or HDL levels are too low, plaque formation accelerates, leading to serious cardiovascular issues.
Causes of hyperlipidemia include obesity, smoking, alcohol consumption, stress, unhealthy lifestyle choices, poor diet (high fat intake), and diabetes. Treatment approaches involve lifestyle modifications such as exercise, weight loss, and a low-fat diet. The primary focus of medicinal treatment is to classify and explain the mechanisms of various anti-hyperlipidemic drugs.
This drug class, also known as statins (e.g., Atorvastatin, Simvastatin), inhibits the HMG-CoA reductase enzyme in the liver. This enzyme is crucial for cholesterol biosynthesis, specifically for converting HMG-CoA to mevalonic acid, a precursor to cholesterol. By blocking this step, statins reduce cholesterol production in the liver. To compensate, the liver increases LDL receptors, pulling more LDL from the bloodstream, thereby lowering blood LDL levels. Statins can reduce blood cholesterol by 20-50% and raise HDL levels. They are typically taken at night because cholesterol synthesis is highest then. Possible side effects include GI disturbances, headaches, and in rare cases, liver toxicity.
Bile acid sequestrants (e.g., Cholestyramine, Colestipol) are resins that bind to bile acids in the intestine, forming an insoluble complex. This complex prevents the reabsorption of bile acids, which are normally recycled back to the liver. As a result, bile acids are excreted in feces, forcing the liver to use more cholesterol from the bloodstream to synthesize new bile acids. This process increases LDL receptor activity, leading to reduced LDL levels in the blood. Side effects include constipation, bloating, and potential malabsorption of fat-soluble vitamins (A, D, E, K).
Fibrates (e.g., Fenofibrate, Gemfibrozil) activate lipoprotein lipase (LPL), an enzyme that breaks down triglycerides in VLDL and chylomicrons. This action reduces triglyceride levels and VLDL production in the liver. Fibrates also increase HDL levels. They are particularly effective for patients with high triglyceride levels (hypertriglyceridemia). Fibrates achieve this by binding to PPAR-alpha receptors, which regulate lipid metabolism. Side effects can include liver toxicity and muscle pain, and they should be used cautiously with statins.
Nicotinic acid (Niacin) primarily acts on adipose tissue to inhibit hormone-sensitive lipase (HSL). HSL is responsible for breaking down stored triglycerides into free fatty acids. By reducing the release of free fatty acids, less fatty acids are available for the liver to synthesize triglycerides and VLDL, thereby decreasing LDL levels. Niacin also increases HDL levels. Common side effects include flushing of the face, hyperuricemia (which can lead to gout), and liver toxicity.
This class includes only one drug, Ezetimibe. It works by selectively inhibiting the absorption of dietary and biliary cholesterol in the small intestine. Specifically, Ezetimibe blocks the Niemann-Pick C1-Like protein (NPC1L1) transporter, which is responsible for cholesterol uptake into intestinal cells. By preventing cholesterol absorption into the bloodstream, Ezetimibe reduces cholesterol delivery to the liver, prompting the liver to increase LDL receptors and clear more LDL from circulation. Ezetimibe is well-tolerated and often used in combination with statins to achieve greater LDL reduction, with minimal side effects.